PATENT CLAIM ANALYSIS

Application Number: 15864327
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "094000"]

Abstract:
The present invention provides for methods and compositions for treating and/or preventing cardiac dysfunction by administering to subject a therapeutically effective amount of a bisphosphonate, functional analogue or a pharmaceutically effective salt thereof.

Claim (Index 1):
An oral or liquid composition comprising zoledronic acid in a therapeutically effective amount to increase ejection fraction in a treated subject, wherein the therapeutically effective amount is formulated to deliver from about 40 ug/kg to about 125 ug/kg to a subject.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 86.0
- Lexical Diversity: 1.12903
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13393248', '14358468', '14140185', '13203188', '14573211']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7170228557111981
- 35 USC 102 Novelty (BERT): 0.5226885194320597
- Combined Prediction Score: 0.6975894220832842
- Mean Citation Score: 219.027706
- Max Citation Score: 334.71255
- Similarity Product: 273.42706613265574

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test